Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway
Endocrine · 2022-03 · 75 (3) · 740-751
DOI: 10.1007/s12020-021-02875-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, online erschienen am 21.09.2021. Verfasst von Shuang Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shanghai University, Shanghai, 200444, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: science and technology commission of shanghai municipality, postdoctoral research foundation of china.
Abstract (Originalsprache)
PURPOSE: Type 2 diabetes mellitus is characterized by insulin resistance and β-cell dysfunction. Elevated free fatty acids-induced lipotoxicity may play a vital role in the pathogenesis of β-cell insulin resistance. Exercise-stimulated myokine irisin has been reported to be closely related to T2DM. However, its function on β-cell insulin signaling and the underlying mechanisms are only partially elucidated as yet. METHODS: High-fat diet-fed C57BL/6J mice and palmitic acid-treated MIN6 cell models were utilized as lipotoxic models. Factors associated with β-cell insulin signaling transduction and inflammatory responses were assessed in these models. Furthermore, the role of irisin in β-cells and the underlying mechanisms were also explored. RESULTS: Irisin effectively decreased lipid levels in HFD mice, enhanced glucose-stimulated insulin secretion and nullified the expressions of inflammatory cytokines in vivo and in vitro experiments. Moreover, irisin improved PI3K/AKT insulin signaling pathway and inhibited TLR4/NF-κB inflammatory signaling pathway in both islets of HFD mice and PA-treated MIN6 cells. Mechanistic analysis indicated that FOXO1 might serve as a bridge between the two pathways. CONCLUSION: Irisin alleviates lipotoxicity-induced β-cell insulin resistance and inflammatory response through the activation of PI3K/AKT/FOXO1 signaling pathways and the inhibition of TLR4/NF-κB signaling pathways. Irisin might provide a novel therapeutic strategy for T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Shanghai University, Shanghai, 200444, China.
- Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
- School of Stomatology, Wenzhou Medical University, Wenzhou, 325000, China.
- Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China. shisheng273@163.com.
Förderung
- science and technology commission of shanghai municipality
- postdoctoral research foundation of china
Zitieren
APA
Zheng, S., Chen, N., Kang, X., Hu, Y., & Shi, S. (2022). Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway. Endocrine, 75(3), 740-751. https://doi.org/10.1007/s12020-021-02875-y
Vancouver
Zheng S, Chen N, Kang X, Hu Y, Shi S. Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway. Endocrine. 2022;75(3):740-751. doi:10.1007/s12020-021-02875-y
BibTeX
@article{Zheng2022,
author = {Zheng, Shuang and Chen, Ningxin and Kang, Xingjian and Hu, Yaomin and Shi, Sheng},
title = {Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway},
journal = {Endocrine},
year = {2022},
volume = {75},
number = {3},
pages = {740--751},
doi = {10.1007/s12020-021-02875-y}
}
EUVIMED